121 related articles for article (PubMed ID: 36925435)
1. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H; Schramm S; Pansikaki K; Jansen S; Hendriks C; Platte M; Konik MJ; Dolff S; Wilde B; Kordelas L; Trilling M; Krawczyk A; Horn PA; Witzke O; Rebmann V
Hum Immunol; 2023 Aug; 84(8):393-400. PubMed ID: 36925435
[TBL] [Abstract][Full Text] [Related]
2. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.
Schwich E; Hò GT; LeMaoult J; Bade-Döding C; Carosella ED; Horn PA; Rebmann V
Front Immunol; 2020; 11():2046. PubMed ID: 32973812
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA-G and ILT-2 receptor in human tuberculosis: Localized versus disseminated disease.
Saurabh A; Thakral D; Mourya MK; Singh A; Mohan A; Bhatnagar AK; Mitra DK; Kanga U
Hum Immunol; 2016 Sep; 77(9):746-53. PubMed ID: 26776460
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
5. Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.
Rohn H; Lang C; Schramm S; Heinemann FM; Trilling M; Gäckler A; Witzke O; Horn PA; Rebmann V
J Immunol Res; 2022; 2022():4829227. PubMed ID: 35600048
[TBL] [Abstract][Full Text] [Related]
6. Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Hoffmann O; Wormland S; Bittner AK; Hölzenbein J; Schwich E; Schramm S; Rohn H; Horn PA; Kimmig R; Kasimir-Bauer S; Rebmann V
Front Immunol; 2023; 14():1188030. PubMed ID: 37283737
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
Chen QY; Zhou WJ; Zhang JG; Zhang X; Han QY; Lin A; Yan WH
Int Immunopharmacol; 2022 Aug; 109():108798. PubMed ID: 35569305
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
[TBL] [Abstract][Full Text] [Related]
9. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule.
Cordeiro JFC; Fernandes TM; Toro DM; da Silva-Neto PV; Pimentel VE; Pérez MM; de Carvalho JCS; Fraga-Silva TFC; Oliveira CNS; Argolo JGM; Degiovani AM; Ostini FM; Puginna EF; da Silva JS; Santos IKFM; Bonato VLD; Cardoso CRB; Dias-Baruffi M; Faccioli LH; Donadi EA; Sorgi CA; Fernandes APM; On Behalf Of The Immunocovid Study Group
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077133
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.
Jasinski-Bergner S; Stoehr C; Bukur J; Massa C; Braun J; Hüttelmaier S; Spath V; Wartenberg R; Legal W; Taubert H; Wach S; Wullich B; Hartmann A; Seliger B
Oncoimmunology; 2015 Jun; 4(6):e1008805. PubMed ID: 26155421
[TBL] [Abstract][Full Text] [Related]
11. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
12. HLA-G and CD8+ regulatory T cells in the inflammatory environment of pre-eclampsia.
Vianna P; Mondadori AG; Bauer ME; Dornfeld D; Chies JA
Reproduction; 2016 Dec; 152(6):741-751. PubMed ID: 27651521
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
14. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.
Lin A; Yan WH
Front Immunol; 2021; 12():788769. PubMed ID: 34938296
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases.
Rashidi S; Vieira C; Tuteja R; Mansouri R; Ali-Hassanzadeh M; Muro A; Nguewa P; Manzano-Román R
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204759
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway.
Liang S; Ristich V; Arase H; Dausset J; Carosella ED; Horuzsko A
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8357-62. PubMed ID: 18550825
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
18. Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients.
Amodio G; Capogrosso P; Pontillo M; Tassara M; Boeri L; Carenzi C; Cignoli D; Ferrara AM; Ramirez GA; Tresoldi C; Locatelli M; Santoleri L; Castagna A; Zangrillo A; De Cobelli F; Tresoldi M; Landoni G; Rovere-Querini P; Ciceri F; Montorsi F; Salonia A; Gregori S
Andrology; 2023 Jan; 11(1):32-44. PubMed ID: 36323494
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
20. Cytokine stimulation of the choriocarcinoma cell line JEG-3 leads to alterations in the HLA-G expression profile.
Persson G; Bork JBS; Isgaard C; Larsen TG; Bordoy AM; Bengtsson MS; Hviid TVF
Cell Immunol; 2020 Jun; 352():104110. PubMed ID: 32387976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
